Probiotics Bismuth Subsalicylate and Abdominal Bloating

Phase 2

• Conditions: Flatulence; R14.3; Abdominal Bloating.

• Registration Number: IRCT20200601047621N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All of the Patients with Abdominal Bloating
Age between 20 and 50 years
Feeling bloated for at least 3 days a month for the last 3 months
The first experience of bloating more than 6 months ago

Exclusion Criteria

Any history of chronic inflammatory disease or structural disease of the gastrointestinal tract
Any serious physical problems or illness, such as inflammation or malignancy
Use of calcium channel blockers in the last 3 months
Severe stress in the last 6 months
Positive family history for Colon Concert
History of inflammatory diseases
Lactase deficiency disease
Celiac disease

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Abdominal Bloadting. Timepoint: Before the start of the study, 2 weeks after the start of the study, 4 weeks after the start of the study, 6 weeks after the start of the study and 8 weeks after the start of the study. Method of measurement: Questionnaire for bloating and IBS-QOL questionnaire.